<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04646083</url>
  </required_header>
  <id_info>
    <org_study_id>E20147</org_study_id>
    <nct_id>NCT04646083</nct_id>
  </id_info>
  <brief_title>Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon</brief_title>
  <acronym>NaviAid 2</acronym>
  <official_title>Depth of Maximal Insertion During Retrograde Enteroscopy Using Colonoscopy With Through-the-scope Balloon Enteroscopy (NaviAid) Compared With Using the Standard Colonoscope Alone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University Health Sciences Center, El Paso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University Health Sciences Center, El Paso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diagnostic modalities for the evaluation of small bowel pathology include video capsule&#xD;
      endoscopy (VCE), antegrade and retrograde device-assisted enteroscopy, CT and MR enterography&#xD;
      (1). Despite VCE being the first-line evaluation modality, it lacks interventional&#xD;
      capability. Deep enteroscopy (DE) allows tissue sampling and other therapeutic interventions&#xD;
      with real-time endoscopic assessment. DE is usually performed with specific endoscopes&#xD;
      (balloon-assisted device or spiral overtube) making it time consuming and there is limited&#xD;
      availability since special instruments and accessories are required.(1,2) The&#xD;
      through-the-scope (TTS) balloon system consists of a balloon catheter designed for anchoring&#xD;
      in the small bowel, inserted through the instrument channel of a standard colonoscope.(3) The&#xD;
      catheter is advanced, the balloon is inflated and anchored in the small intestine and the&#xD;
      endoscope slides over the guiding catheter to the inflated balloon. The most common&#xD;
      indications for DE are obscure GI bleeding, iron deficiency anemia, abnormal capsule&#xD;
      endoscopy and chronic diarrhea. As compared to spiral, single-or double-balloon enteroscopy,&#xD;
      TTS (NaviAid, SMART Medical Systems Ltd, Ra'anana, Israel) is a simpler technique, which&#xD;
      requires less investment in infrastructure. The balloon catheter is advanced blindly in front&#xD;
      of a standard adult colonoscope as it bends around the curves of the small bowel. To prevent&#xD;
      perforation/trauma the catheter is fitted with a soft silicone tip which easily bends under&#xD;
      pressure.&#xD;
&#xD;
      Insertion depth can be calculated during the withdrawal of the enteroscope. The Aim of the&#xD;
      study: To compare the depth of maximal ileal insertion between through-the-scope balloon&#xD;
      enteroscopy (NaviAid) with enteroscopy using the adult colonoscope (Olympus CF-190) alone, in&#xD;
      the same patient, in a prospective cohort at University Medical Center of El Paso, Texas.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Aim of the study: To compare the depth of maximal ileal insertion between&#xD;
      through-the-scope balloon enteroscopy (NaviAid) with enteroscopy using the adult colonoscope&#xD;
      (Olympus CF-190) alone, in the same patient, in a prospective cohort from August 1, 2020 to&#xD;
      July 31, 2023 at University Medical Center of El Paso, Texas.&#xD;
&#xD;
      Depth of insertion is correlated with diagnostic yield, meaning that we would like to&#xD;
      ascertain if the use of the colonoscope with NaviAid will result in greater depth of&#xD;
      insertion and potentially more findings of small bowel abnormalities than using a colonoscope&#xD;
      alone.&#xD;
&#xD;
      It is assumed that this is the case, but we want to show it and quantify it.&#xD;
&#xD;
      HYPOTHESIS:&#xD;
&#xD;
      The depth of ileal insertion is greater with the use of through-the-scope balloon enteroscopy&#xD;
      (NaviAid) when compared with enteroscopy using the standard adult colonoscope (Olympus&#xD;
      CF-190) alone.&#xD;
&#xD;
      OBJECTIVE:&#xD;
&#xD;
      To compare the depth of maximal ileal insertion between through-the-scope balloon enteroscopy&#xD;
      (NaviAid) with the adult colonoscope (Olympus CF-190) alone, in the same patient, in a&#xD;
      prospective cohort at University Medical Center of El Paso, Texas.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>depth of maximal insertion into ileum</measure>
    <time_frame>during the enteroscopy of the patient, about one hour</time_frame>
    <description>depth of insertion is measured on withdrawal of colonoscope by estimating in 10 cm intervals</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>diagnostic yield of retrograde enteroscopy</measure>
    <time_frame>during the enteroscopy of the patient, bout one hour</time_frame>
    <description>proportion of studies with significant findings on enterosocpy</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Obscure Gastrointestinal Bleeding</condition>
  <condition>Anemia, Iron Deficiency</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for evaluation of obscure gastrointestinal bleeding with nondiagnostic&#xD;
        upper and lower endoscopy with suspicion of distal small bowel source based on either&#xD;
        abnormal videocapsule endoscopy or imaging study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Sign Informed Consent Form&#xD;
&#xD;
          2. Patients age between 18-90 years&#xD;
&#xD;
          3. Patients in which retrograde enteroscopy is indicated for any of the following:&#xD;
&#xD;
        abnormal video capsule endoscopy non-diagnostic upper and lower endoscopy obscure&#xD;
        gastrointestinal bleeding iron deficiency anemia non-diagnostic upper endoscopy and&#xD;
        abnormal CT Hemodynamically stable&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability to sign Informed Consent Form&#xD;
&#xD;
          2. Pregnancy and breast feeding&#xD;
&#xD;
          3. Prior colon resection&#xD;
&#xD;
          4. Patients with known strictures&#xD;
&#xD;
          5. Patients with altered anatomy&#xD;
&#xD;
          6. Inadequate bowel preparation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc J Zuckerman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Tech University Health Sciences Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marc J Zuckerman, MD</last_name>
    <phone>9156306163</phone>
    <phone_ext>9156306163</phone_ext>
    <email>marc.zuckerman@ttuhsc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nancy A Casner, BS</last_name>
    <phone>915-215-5170</phone>
    <email>Nancy.Casner@ttuhsc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Texas Tech University Health Science Center El Paso</name>
      <address>
        <city>El Paso</city>
        <state>Texas</state>
        <zip>79905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Zuckerman, MD</last_name>
      <phone>915-630-6163</phone>
      <email>marc.zuckerman@ttuhsc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Nancy Casner, MS</last_name>
      <phone>915-215-5170</phone>
      <email>nancy.casner@ttuhsc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Marc Zuckerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Chavez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sherif Elhanafi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>November 20, 2020</study_first_submitted>
  <study_first_submitted_qc>November 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2020</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Tech University Health Sciences Center, El Paso</investigator_affiliation>
    <investigator_full_name>Marc Zuckerman</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>retrograde enteroscopy</keyword>
  <keyword>small bowel bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
    <mesh_term>Anemia, Iron-Deficiency</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

